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Aneuploidy, a condition characterized by chromosome gains and losses, causes reduced fitness and numerous cel-
lular stresses, including increased protein aggregation. Here, we identify protein complex stoichiometry imbalances
as a major cause of protein aggregation in aneuploid cells. Subunits of protein complexes encoded on excess
chromosomes aggregate in aneuploid cells, which is suppressed when expression of other subunits is coordinately
altered. We further show that excess subunits are either degraded or aggregate and that protein aggregation is nearly
as effective as protein degradation at lowering levels of excess proteins. Our study explains why proteotoxic stress is
a universal feature of the aneuploid state and reveals protein aggregation as a form of dosage compensation to cope
with disproportionate expression of protein complex subunits.
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Eukaryotes have a problem: Subunits of protein complex-
es are not encoded in operons. Although eukaryotes have
evolved to coordinate expression of subunits of the same
complex (Li et al. 2014; Taggart and Li 2018), changes in
gene dosage of a subset of subunits of a protein complex,
transient gene copy number imbalances during DNA rep-
lication, or fluctuations in gene expression can disrupt
this coordinate expression, leading to the production of
complex subunits that lack their binding partners. These
orphan subunits have the potential to misfold and cause
proteotoxic stress. How eukaryotic cells deal with stoi-
chiometric imbalances is a fundamental yet largely unex-
plored question.
Aneuploidy represents an especially dramatic case of
gene dosage alteration because changes in autosome
copy number generally lead to a corresponding change
in the levels of RNAs and proteins produced by genes lo-
cated on aneuploid chromosomes (Pavelka et al. 2010;
Torres et al. 2010; Dephoure et al. 2014). Not surprisingly,
these dramatic alterations in cellular protein composition
significantly impact cellular physiology, causing cell pro-
liferation defects, metabolic alterations, and oxidative
stress (for review, see Santaguida andAmon 2015). Protein
homeostasis defects are especially prevalent in aneuploid
cells. In budding yeast, many different aneuploidies har-
bor more protein aggregates, display decreased chaperone
activity, and exhibit sensitivity to conditions that inter-
ferewith proteasomal degradation (Torres et al. 2007; Oro-
mendia et al. 2012). Inmammals, aneuploidy also disrupts
protein homeostasis, leading to altered autophagy, abnor-
mal protein folding, and accumulation of protein aggre-
gates (Tang et al. 2011; Stingele et al. 2012; Donnelly
and Storchová 2014; Santaguida et al. 2015). Why protein
aggregation is so widespread in aneuploid cell lines was
not understood.
We previously generated a series of haploid yeast
strains, each harboring an extra copy of one of the 16 yeast
chromosomes (referred to here as disomes) (Torres
et al. 2007). Analysis of the localization of Hsp104, a dis-
aggregase that associates with protein aggregates (Liu
et al. 2010), showed that gain of any of the 16 yeast
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chromosomes causes an increase in the number of cells
harboring Hsp104 foci, providing evidence for increased
protein aggregation (Oromendia et al. 2012). Here we
determine the molecular basis of this phenotype. We
found that subunits of protein complexes encoded on ex-
cess chromosomes aggregate in aneuploid cells. Our anal-
yses also provide insights into how cells respond to
protein stoichiometry imbalances. Protein aggregation
can quantitatively deplete excess protein from the cyto-
sol. We conclude that protein aggregation commonly per-
forms functional dosage compensation.
Results
Identification of proteins that aggregate in aneuploid
yeast cells
Previous studies of proteotoxic stress in aneuploidy had
shown that cells with defined chromosome gains or ran-
domly generated unknownkaryotypes harbored increased
levels of protein aggregates (Oromendia et al. 2012; Stin-
gele et al. 2012; Santaguida et al. 2015). To gain insight into
why protein aggregation is so common in aneuploid cells,
we determined the composition of protein aggregates in
disomic yeast strains. We isolated protein aggregates
from disomic yeasts strains by a stringent differential cen-
trifugation method (Koplin et al. 2010). Hsp104 was en-
riched in aggregate fractions (Fig. 1A); however, we note
that aggregates isolated in this manner may not contain
all Hsp104-decorated aggregates and also may contain ag-
gregates not recognized byHsp104. Analysis of protein ag-
gregates by SDS-PAGE revealed that protein aggregation
is increased in aneuploid cells. Cells that missegregate
chromosomes at a high frequency because they carry a
temperature-sensitive allele in the kinetochore compo-
nent encoding gene NDC10 harbored high levels of
protein aggregates (Fig. 1B). Increased amounts of aggre-
gated proteins were also observed in haploid cells disomic
for chromosome V (Fig. 1B).
Having established that aneuploidy causes an increase
in protein aggregates that can be isolated by differential
centrifugation, we used stable isotope labeling by amino
acids in cell culture (SILAC) mass spectrometry (MS) to
identify proteins that preferentially aggregate in 12 differ-
ent disomic yeast strains (Fig. 1C; Supplemental Fig. S1A;
Supplemental Data S1; Ong et al. 2002; Shevchenko et al.
2006). Reproducibility was high between individual ex-
periments: 70% of proteins were identified in repeats of
individual experiments (Supplemental Fig. S1B,C). Al-
though biological replicates were well correlated, the
mean of the SILAC ratios for all proteins combined in ag-
gregates varied between replicates of the same disome
(e.g., for disome II, the means were 0.59, 0.69, and 0.30).
To account for this variability and to be able to conduct
analyses on the aggregate data set as a whole, we mean-
centered all experiments such that the mean relative
enrichment was equal across experiments (Fig. 1C). Each
experiment was mean-centered to 0 by subtracting the
mean of all SILAC ratios in that experiment from all
data points. To return the normalized values to a baseline
that more closely resembles the increase in protein aggre-
gation in disomic strains observed in the raw data, a con-
stant (log2 0.27) was added to all normalized data points.
This constant is themean log2 ratio of all euploid-encoded
proteins in the data set prior to normalization. Of note, we
also identified proteins that were enriched in aggregates
isolated from euploid strains compared with disome
strains. However, in triplicate experiments for disome II,
only four proteins (1.4%) were enriched more than two-
fold in aggregates from euploid cells, and their enrichment
across replicate experiments was highly variable (Supple-
mental Fig. S1D,E).
Which proteins aggregate in disomic yeast strains? The
similar banding patterns of wild-type (WT) and aneuploid
aggregates on SDS-PAGE gels (Fig. 1B) indicated that ag-
gregates were composed of the same proteins but that
they aggregate more in aneuploid strains than in euploid
strains. Comparison of the banding pattern of protein ag-
gregates on SDS-PAGE with the banding pattern of puri-
fied ribosomes further suggested that protein aggregates
of both euploid and disomic yeast strains were enriched
for ribosomes (Supplemental Fig. S2A). To estimate the
contribution of ribosomes to protein aggregates in disomic
yeast strains, we first determined the abundance of pro-
teins in aggregates in each strain relative to its euploid ref-
erence by summing the raw total intensity of all heavy-
labeled peptides and all light-labeled peptides and then
calculating a ratio of the two (Supplemental Fig. S2B).
Nine out of 12 disomic strains contained more aggregated
protein than euploid controls by this estimate. We then
calculated the signal of each ribosomal protein as a per-
centage of the total signal for all aggregated proteins and
determined that 75%of aggregatedproteinswere ribosom-
al proteins. Interestingly, the disomic strainswith fewer ri-
bosomes aggregating were the same strains that showed
lower levels of total aggregate burden (Supplemental Fig.
S2B,C), confirming that ribosomes make up the majority
of aggregating proteins in disomic yeast strains. Two lines
of evidence indicate that it is assembled ribosomes rather
than individual subunits that accumulate in aggregates.
First, almost all excess ribosomal subunits are quantita-
tively degraded in disomic yeast strains (Dephoure et al.
2014). Second, the Coomassie staining pattern of protein
aggregates on SDS-PAGE resembles the pattern of purified
intact ribosomes (Supplemental Fig. S2A). We conclude
that ribosomes are abundant in aggregates purified by
our method in both euploid and aneuploid yeast strains
but aggregate more in disomes.
To determine which proteins other than ribosomes are
found in aggregates purified by our differential centrifuga-
tion method, we assessed the presence of known phase-
separated structures such as P bodies, stress granules, or
nucleoli in purified aggregates (Banani et al. 2017) using
the annotations by Jain et al. (2016). P-body proteins
were significantly underrepresented in aggregates com-
pared with total lysates (Supplemental Fig. S2D). We
also identified fewer stress granule proteins and nucleolar
proteins in aggregates compared with total lysates; how-
ever, this difference was not significant (Supplemental
Fig. S2D). We conclude that components of phase-
Brennan et al.
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separated structures are not significantly enriched in our
aggregate preparations.
Next, we conducted an unbiased gene ontology (GO)
analysis (Supplemental Fig. S2E) to determine which pro-
teins were in fact enriched in aggregates isolated from an-
euploid strains. Macromolecular complex was the GO
termmost significantly associated with proteins in aggre-
gates, suggesting that complex subunits may be predis-
posed to aggregation. Ribosomes were the second most
significant GO term, confirming our observation that
the organelle is enriched in our aggregate preparation.
The term “nonmembrane-bound organelle” (fourth most
significant GO term) includes ribosomes, which likely
drives the significance of this GO term. The third most
significant GO term was “cell,” which we interpret to
mean that all GO terms with P-values larger than this
generic GO term, which includes the GO terms mito-
chondrion, nucleolus, and membrane, are not likely to
bemeaningful. This conclusion is supported by our obser-
vation that proteins known to be components of the nu-
cleolus are not enriched in aggregates isolated from
disomic yeast strains.
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Figure 1. Identification of proteins that aggre-
gate in aneuploid yeast cells. (A) Total lysate, ag-
gregates, and soluble fractions obtained from
exponentially growing cells expressing Hsp104-
eGFP (A31392) were analyzed for Hsp104 and
Pgk1 abundance. (B) Protein aggregates and total
lysates were prepared from euploid cells (wild
type [WT], A35797), ndc10-1 cells (ndc10-1,
A13413) grown for 4 h at 30°C, disomeV cells (dis-
ome [Dis] V, A28265), and euploid cells (A2587) af-
ter an 8-min heat shock at 42°C (heat shock).
Total lysates and aggregate fractions were subject-
ed to SDS-PAGE and stained with Coomassie.
(C ) WT and disome cells were grown to exponen-
tial phase in synthetic complete (SC) medium
containing heavy lysine and light lysine, respec-
tively. Aggregated proteins are separated into
two dot plots,with red dots indicating proteins en-
coded on the duplicated chromosome and gray
dots indicating proteins encoded on euploid chro-
mosomes. The first column represents aggregates
purified from a mixed sample of heavy lysine-la-
beled WT and light lysine-labeled WT. Lines rep-
resent mean and standard deviation (SD). The
top dashed line at log2 1.27 shows the cutoff
used to define aggregating proteins. (∗∗) P <0.01;
(∗∗∗∗) P<0.0001, Mann-Whitney test. (D) The av-
erage (Avg) aggregate enrichment of proteins en-
coded on euploid chromosomes that were
identified in aggregates of at least three out of 12
disomes. Only proteins with an average enrich-
ment of ≥log2 1.27 as measured in C are shown.
Error bars indicate SD. (E) The enrichment of pro-
teins fromDwas comparedwith their enrichment
in aggregates purified from cells treated with rad-
icicol (orange) or cells harboring the rpn6-1 allele
(purple) from Supplemental Figure S4. An asterisk
indicates proteins that were not quantified in ei-
ther the radicicol or rpn6-1 experiments because
they did not pass the detection threshold in aggre-
gates purified from the reference strain but were
readily detected in aggregates isolated from radici-
col-treated or rpn6-1 cells. (F ) The percentage of
proteins encoded by the duplicated chromosome
that were enriched at a level greater than the ag-
gregation threshold of log2 1.27 (black bars) and
the percentage of proteins encoded by the duplicated chromosome as a fraction of the whole proteome (gray bars). (n.s.) Not significant;
(∗∗∗∗) P <0.0001, cumulative distribution function for a hypergeometric distribution. (G) The percentage of proteins encoded by the dupli-
cated chromosome that were not quantified by stable isotope labeling by amino acids in cell culture (SILAC) mass spectrometry (MS)
because the heavy-labeled (WT) peptides did not pass the detection threshold (black bars) and the percentage of proteins encoded by
the duplicated chromosome as a fraction of the whole proteome (gray bars). (n.s.) Not significant; (∗∗) P< 0.01; (∗∗∗) P <0.001; (∗∗∗∗) P<
0.0001, cumulative distribution function for a hypergeometric distribution.
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Next, we examined the physical and chemical pro-
perties of aggregating proteins. For this analysis, we com-
pared aggregating proteins with the whole yeast proteome
and proteins identified in lysates from which the aggre-
gates were purified. Proteins in both aggregates and total
lysates had more disordered regions than the whole prote-
ome (Supplemental Fig. S3A). Hydrophobicity did not af-
fect aggregation propensity (Supplemental Fig. S3B).
Amino acid composition appeared to affect protein aggre-
gation in aneuploid yeast strains. Aggregated proteins
weremore basic and contained slightlymore aromatic res-
idues than proteins identified in lysates (Supplemental
Fig. S3C–E). Whether these features influence aggregation
propensity remains to be determined. However, based on
our knowledge of the effects of aneuploidy on cell physiol-
ogy and the fact that “macromolecular complex” was the
most significant GO term describing proteins that aggre-
gate in disomic yeast strains, we can envision two classes
of proteins that aggregate in disomic yeast strains: Class 1
is proteins that rely extensively on protein folding path-
ways to achieve their native conformation. Such proteins
could aggregate because protein quality control is compro-
mised in aneuploid yeast strains (Torres et al. 2010; Oro-
mendia et al. 2012). Aggregation of these proteins ought
to be independent of the identity of the aneuploid chromo-
somes and should occur in multiple different disomic
yeast strains. Class 2 is proteins encoded by the duplicated
chromosome. Such proteins could aggregate because they
are in excess. We first focused on proteins in class 1.
Proteins that aggregate in multiple disomes also
aggregate in cells with compromised protein quality
control
Aneuploid cells experience proteotoxic stress (Tang et al.
2011; Oromendia et al. 2012; Stingele et al. 2012; Santa-
guida et al. 2015). Proteins that rely extensively on protein
folding pathways to achieve their native conformation
could thus aggregate in aneuploid cells more than in eu-
ploid cells. To identify proteins that exhibit an increased
aggregation due to the aneuploid state, we identified pro-
teins that (1) were encoded on euploid chromosomes, (2)
aggregated in at least three different disomic yeast strains,
and (3) had an average enrichment of at least 2.4-fold (log2
1.27) in disomic aggregates. We arrived at this cutoff for
enrichment of proteins in disome aggregates using a false
discovery rate (FDR) of 5% (see the Materials and Meth-
ods). This analysis identified 22 proteins (Fig. 1D; Supple-
mental Data S2).
If proteins aggregate in multiple different disomic
strains because proteostasis is compromised, they should
also aggregate in euploid cells in which protein quality
control pathways are inhibited. To test this, we analyzed
protein aggregates of cells harboring a temperature-sensi-
tive mutation in the proteasome subunit encoding gene
RPN6 (Isono et al. 2005) and of cells treated with the
Hsp90 inhibitor radicicol (Supplemental Fig. S4; Supple-
mental Data S2). For the 22 proteins identified as aggregat-
ing in multiple disomic strains, we obtained quantitative
information for 14 in aggregates of either rpn6-1 cells, rad-
icicol-treated cells, or both. Of these, 13 (94%) were en-
riched 2.4-fold (log2 1.27) in aggregates of rpn6-1 cells,
radicicol-treated cells, or both (P< 0.001, hypergeometric
cumulative distribution function) (Fig. 1E). We conclude
that proteostasis deficiency causes protein aggregation
in aneuploid cells regardless ofwhether gene copy number
is altered.
Duplicated proteins are highly enriched in aneuploid
aggregates
We next examined proteins encoded on disomic chromo-
somes. These proteins were indeed significantly enriched
in aggregates isolated from their respective disomic
strains (Fig. 1C, red dots). To determine the number of pro-
teins that aggregate because they are produced from two
rather than one gene copy, we used a cutoff of 2.4-fold
(log2 1.27; based on a 5% FDR, described above) to define
aggregate enrichment. We identified 437 proteins that
were enriched in aggregates in a disome-specific manner
(Fig. 1F; Supplemental Data S1). For example, chromo-
some II encodes for 13% of the yeast proteome when du-
plicated, yet 36% of proteins that aggregate in strains
disomic for chromosome II are encoded on chromosome
II. Similarly dramatic results are observed in all disomic
strains (Fig. 1F). We further note that this enrichment of
disome-encoded proteins in aggregates underestimates
proteins that aggregate because they are produced in ex-
cess. Proteins that fall below an established signal to noise
ratio in either the heavy or light channel cannot be includ-
ed because a SILAC ratio cannot be calculated. To miti-
gate this limitation, we examined proteins that did not
pass the signal to noise threshold in one channel but had
a signal to noise ratio of at least twice the threshold in
the other channel (see the Materials and Methods). This
identified an additional 320 proteins that were quantified
only in disome aggregates comparedwith just 72 thatwere
identified only in aggregates of the euploid control strain
(Supplemental Data S1). Importantly, 92 of the proteins
quantified only in aggregates of disomic strains were en-
coded on the disomic chromosome, as opposed to just
two that were quantified only in aggregates of euploid
strains (Fig. 1G). We conclude that at least 529 proteins
(437 proteins identified as enriched in disomes compared
with WT aggregates + 92 identified only in disome aggre-
gates) aggregatewhen their gene copy number is increased
by twofold.
Increasing gene copy number by one causes protein
aggregation in human cells
Is protein aggregation a feature of aneuploidy that is con-
served across eukaryotes? To address this question, we an-
alyzed protein aggregation in near-diploid human RPE-1
cells and two derivatives that were trisomic for chromo-
some 12 or 21 (Stingele et al. 2012). As in yeast, proteins
most enriched in aggregates were encoded on the trisomic
chromosome. Within the 10th percentile of proteins most
enriched in trisomy 12 aggregates, 16.2% of proteins were
encoded by chromosome 12 (Fig. 2A,B; Supplemental
Brennan et al.
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Data S3). This enrichment was highly significant (Fisher’s
exact test, P< 0.0001). In contrast, proteins encoded by
other chromosomes had no significant enrichment, with
the exception of proteins encoded by chromosome 4,
which were slightly depleted (Fisher’s exact test, P=
0.0297). We conclude that chromosome 12-encoded pro-
teins are enriched in aggregates of trisomy 12 cells.
Enrichment of chromosome 21-encoded proteins was
not evident in aggregates purified from trisomy 21 cell
lines (Fig. 2A,C; Supplemental Data S3), most likely due
to the fact that chromosome 21 is the gene-poorest chro-
mosome in humans. To increase protein aggregation in
trisomy 21 cells, we prevented protein degradation by in-
hibiting the proteasome and lysosomal degradation with
MG-132 and chloroquine, respectively. In this experi-
ment, we observed that within the 10th percentile of pro-
teins most enriched in trisomy 21 aggregates, 3.2% were
encoded by chromosome 21. Overall, proteins encoded
on chromosome 21 represent only 1%of proteins in aggre-
gates (Fig. 2D,E; Supplemental Data S3). This enrichment
was highly significant (Fisher’s exact test, P = 0.0005). In
contrast, proteins encoded on other chromosomes did
not show significant enrichment. Among the chromo-
some 21-encoded proteins enriched in aggregates were
two proteins known to contribute to disease phenotypes
in trisomy 21: DOPEY2, a protein implicated in causing
mental retardation (Rachidi et al. 2005), and APP, the pre-
cursor of the Alzheimer’s disease-associated amyloid-β.
We conclude that aggregation of proteins encoded on ex-
cess chromosomes is also a feature of aneuploidy in hu-
mans. We note that the enrichment of proteins encoded
on excess chromosomes is less apparent in trisomic hu-
man cells than in disomic yeast cells. This is to be expect-
ed. Gain of a copy of a chromosome in a diploid cell causes
fewer protein imbalances than gain of a chromosome in a
haploid cell.
Stoichiometric imbalance of protein complexes can
cause protein aggregation
Wenext examined themechanism bywhich altering gene
copy number causes protein aggregation in aneuploid
cells. Protein complex analysis using the annotation by
Pu et al. (2009) showed that 44.2% of the 529 proteins
that aggregated in disomic yeast strains when encoded
on an excess chromosome were subunits of protein com-
plexes (Fig. 3A). By comparison, only 29.2%of proteins en-
coded by euploid chromosomes that were enriched in
aggregates were subunits of protein complexes (Fig. 3A).
Wehypothesized that the enrichment of duplicated pro-
tein complex subunits in disome aggregates was due to
protein complex subunits requiring binding to other sub-
units to acquire their native state. This hypothesis pre-
dicts that when gene copy number of the other complex
subunits is altered in accordance with expression of the
subunit produced in excess, aggregation should be pre-
vented. We tested this prediction by studying the eIF2
complex, which is required for translation initiation and
is composed of three subunits. The eIF2 γ subunit
Gcd11 is encoded on chromosome V (Fig. 3B). Gcd11
was found in aggregates isolated from yeast strains diso-
mic for this chromosome but returned to euploid levels
in aggregates from disome V strains in which one copy
of GCD11 was deleted (Fig. 3C–E). In fact, a single extra
copy of GCD11 in an otherwise euploid strain was suffi-
cient to cause Gcd11 aggregation (Fig. 3C–E). Thus,
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Figure 2. Aggregate analysis in trisomic
human cells. (A) RPE-1 cells and RPE-1 cells
trisomic for either chromosome 12 or
chromosome 21 were cultured in medium
containingheavy lysineor light lysine, respec-
tively, for 10 generations.Within each experi-
ment, euploid-encoded proteins (gray dots)
wereplotted separately fromtrisome-encoded
proteins (red dots). (∗∗∗∗) P<0.0001; (n.s.) not
significant,Mann-Whitney test. (B,C ) Enrich-
ment of chromosome 12-encoded (B) and
chromosome 21-encoded (C ) proteins in total
aggregates (gray bars) and among the top 10%
most highly enriched aggregated proteins
(black bars). (n.s.) Not significant; (∗∗∗∗) P<
0.0001, cumulative distribution function for
a hypergeometric distribution. (D) Euploid
and trisomy 21 cells were treated with
25nMchloroquine and1µMMG-132, and ag-
gregates were plotted as in A. (∗∗∗) P<0.001,
Mann-Whitney test. (E) Enrichment of chro-
mosome 21-encoded proteins in total aggre-
gates (gray bar) and among the top 10%most
highly enriched aggregated proteins (black
bar). (∗∗∗∗) P<0.0001, cumulative distribution
function for a hypergeometric distribution.
(Ts) Trisome; (Chr) chromosome.
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increased gene dosage of GCD11 is necessary and suffi-
cient to cause aggregation of the protein. It is worth noting
thatGcd11 aggregated less when expressed in excess by it-
self than when overexpressed due to an extra copy of chro-
mosome V. This observation suggests that proteotoxic
stress caused by disomy of chromosome V exaggerates ag-
gregation of Gcd11.
To test whether aggregation of Gcd11 in disome V
strains can be prevented by doubling the gene copy num-
ber of the eIF2 α subunit encoding gene SUI2 and the
eIF2 β subunit encoding gene SUI3, we introduced a cen-
tromeric plasmid carrying both genes under their native
promoters into disome V strains. Expression of SUI2 and
SUI3 dramatically reduced Gcd11 aggregation in disome
V cells (Fig. 3F–H). We note that expression of SUI2 and
SUI3 also increased Gcd11 levels in lysates (Fig. 3F). A
pool of Gcd11 is degraded when expressed in excess
(Dephoure et al. 2014). Increased expression of SUI2
and SUI3 likely also protects Gcd11 from degradation.
We conclude that stoichiometric imbalance of protein
complexes can cause protein aggregation in aneuploid
cells.
Excess proteins either aggregate or are degraded
Previous studies showed thatmany proteins that function
in protein complexes are degradedwhen in excess in aneu-
ploid cells, restoring their levels to euploid or near-euploid
levels (Dephoure et al. 2014; Ori et al. 2016; Gonçalves
et al. 2017). We observed that many proteins aggregate
when in excess. An important question regarding these
two observations is whether excess subunits are down-
regulated by both mechanisms or are neutralized by one
or the other. To distinguish between these possibilities,
we analyzed protein degradation and aggregation propen-
sity for all disome-encoded proteins identified in our pro-
tein aggregate analysis and the protein degradation
analysis of Dephoure et al. (2014). Note that both data
sets were created with the same strains. Analysis of the
relative abundance of proteins encoded on disomic chro-
mosomes confirmed that the two data sets were indeed
similar to each other despite slight differences in growth
conditions (Supplemental Fig. S5).
We first asked whether relative abundance of a protein
in total lysates correlates with protein aggregation; in
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Figure 3. Stoichiometric imbalances of protein
complex subunits cause protein aggregation.
(A) The percentage of proteins encoded by dupli-
cated chromosomes enriched by log2 ≥1.27 in
aggregates (red), the percentage of proteins en-
coded by euploid chromosomes enriched by
log2 ≥1.27 in aggregates (gray), and the percent-
age of proteins in the genome (black) that are an-
notated to form protein complexes by Pu et al.
(2009) were calculated. (∗∗∗∗) P <0.0001; (n.s.)
not significant, cumulative distribution func-
tion for a binomial distribution. (B) Diagram of
eIF2 complex stoichiometry in disome V cells.
(C ) Gcd11-HA in aggregates and total lysates
in WT (A40189), disome V (A40190), disome V
GCD11-HA/gcd11Δ (A40191), and WT URA3::
GCD11-HA (WT+GCD11; A40192) cells.
Only one of the two GCD11 genes in disome
V cells was tagged with HA to ensure that pro-
tein levels are comparable between strains.
(D) Quantification of Western blots in C. n=3;
SD. (∗∗∗) P <0.001, t-test. (E) Cells were grown
as in C, and mRNA levels for eIF2 subunits
were determined. Values were normalized to
ACT1 and then to WT expression levels. n=3;
SD. (F–H) Western blot, relative aggregation
quantification, and mRNA expression for WT
(A40193), disome V (A40194), and disome V
pSUI2/SUI3 (A40195) cells as described in C–
E. n= 3; SD. (∗∗) P <0.01, t-test. (Dis) Disome;
(rel) relative.
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other words: Is a protein more likely to aggregate when its
levels in total lysate are higher than in a euploid strain?
We indeed observed a weak but significant correlation
(Fig. 4A). This observation indicates that proteins that
are dosage-compensated by protein degradation are less
likely to be found in aggregates. Because excess cytoplas-
mic ribosomal subunits are almost exclusively degraded
(Dephoure et al. 2014), we also asked whether the correla-
tion was driven by ribosomal proteins. Removing cyto-
plasmic ribosomal proteins from the data set weakened
the correlation between abundance of proteins in extracts
and their propensity to aggregate, but it was still signifi-
cant (Supplemental Fig. S6A).
To further assess whether protein aggregation and deg-
radation are mutually exclusive, we analyzed the data us-
ing cutoffs previously set to define a protein to aggregate
or be degraded when in excess. Dephoure et al. (2014) de-
fined a disome-encoded protein as degraded when its
abundance in extracts relative to a euploid reference was
1.52 (log2 0.6) instead of the expected 2 (log2 1). We defined
any disome-encoded protein as aggregated when it was
found enriched 2.4-fold (log2 1.27) in aggregates (Fig. 1).
Based on these criteria, only 100 out of 983 (10%) disomic
proteins were considered to both aggregate and be degrad-
ed when in excess. This is evident by the fact that the top
left quadrant in the graph in Figure 4A is underpopulated
(Fisher’s exact test, P= 0.0045). This mutually exclusive
behavior of disome-encoded proteins was not driven by ri-
bosomal proteins because we observed the same under-
population of the top left quadrant when we removed
ribosomal proteins (Supplemental Fig. S6A). When we re-
stricted our analysis to subunits of protein complexes,
only 67 out of 424 (16%) proteins were both enriched in
disome aggregates and degraded when in excess (Fisher’s
exact test, P = 0.0012) (Fig. 4B), although we note that
this observed lack of overlap between aggregation and deg-
radation was, to a significant extent, driven by ribosomal
proteins (Supplemental Fig. S6B).
Another way to assess whether disome-encoded pro-
teins aggregate or are degraded but not both is to ask
whether disome-encoded proteins that are highly en-
riched in aggregates are present in total lysates at the two-
fold level expected for disome-encoded proteins or
whether their levels are lower. We found that disome-en-
coded proteins that are enriched in aggregates are present
at levels close to the expected level of twofold, indicating
that they are not degraded (Fig. 4C). In contrast, levels of
proteins that were detected in aggregates but not enriched
in aggregateswere lower in total lysates (Fig. 4C). Removal
of ribosomal subunits from the analysis did not alter this
conclusion (Supplemental Fig. S6C). The results were
even more striking when we focused our analysis on dis-
ome-encoded proteins that are part of protein complexes
(Fig. 4D; Supplemental Fig. S3D). We conclude that,
when present in excess, proteins have a preferred fate of ei-
ther degradation or aggregation.
Protein complex subunits that aggregate when in excess
have lower turnover rates than degraded subunits
What determines whether excess protein complex sub-
units aggregate or are degraded? Computational analyses
revealed that both classes of subunits harbor large pro-
tein–protein interfaces within their complexes compared
BA
C D
Figure 4. Excess proteins are either aggre-
gated or degraded. (A,B) Correlation between
enrichment in protein aggregates (measured
in Fig. 1C) and relative protein levels (mea-
sured in disome lysates by Dephoure et al.
2014) was determined for all proteins encod-
ed by the duplicated chromosome quantified
in both data sets (A) and duplicated subunits
of protein complexes (B). Spearman cor-
relation of 0.1810 (P=1.2 × 10−8) in A and
0.2814 (P <0.0001) in B. Dashed lines indi-
cate thresholds for proteins that are con-
sidered aggregated (Y-axes) or degraded
(X-axes). The number of proteins that fall
into each quadrant is indicated. (C,D) All du-
plicated proteins (C ) and duplicated complex
subunits (D) were separated into two bins: (1)
aggregated proteins (red bars), whichwere de-
fined as proteins with an enrichment of at
least log2 1.27 in disomic aggregates, and (2)
nonaggregated proteins (gray bars), which
were defined as proteins with an enrichment
of log2 ≤0.727. Average relative levels in dis-
ome lysates as measured by Dephoure et al.
(2014) are plotted. Error bars represent 95%
confidence intervals. (∗∗∗∗) P< 0.0001,
Mann-Whitney test. (Dis) Disome.
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with proteins that neither aggregate nor are degraded (Fig.
5A; Supplemental Data S4;Marsh et al. 2013). This is con-
sistent with earlier work inmammalian cells demonstrat-
ing that protein complex subunits with larger interfaces
tend to be unstable and rapidly degraded when not bound
to their partners (McShane et al. 2016). If overexpressed
relative to other components of the complex, these large
interfaces could facilitate inappropriate protein–protein
interactions, leading to aggregation instead of degradation
(Levy et al. 2012).
Given that both excess protein complex subunits that
are degraded and those that aggregate harbor large pro-
tein-binding interfaces, we hypothesized that their fate
could be determined by differences in recognition by the
ubiquitin/proteasome or lysosomal degradation systems.
Previous work showed that degradation of proteins that
are encoded on a disomic chromosome can be prevented
by treating disomic cells with the proteasome inhibitor
MG-132 and the lysosomal-degradation inhibitor chloro-
quine (Fig. 5B, right part of the graph; Dephoure et al.
2014). Importantly, we found that preventing protein deg-
radation did not affect overall levels of individual proteins
that aggregate (Fig. 5B, left part of the graph) and average
levels of all proteins that aggregate (Fig. 5C; Supplemental
Data S4). Therefore, proteins found in aggregates generally
have low turnover rates.
To further assess whether protein stability determines
whether a protein aggregates, we analyzed the effects of
proteasome inhibition on the fate of proteins that are nor-
mally degraded when in excess. Partial inhibition of the
proteasome using a temperature-sensitive rpn6-1mutant
grown at the semipermissive temperature (30°C) caused
a general increase in protein aggregation for all proteins
in disome II cells (Fig. 5D; Supplemental Data S4). Sixty-
seven disomic proteins are normally degraded in cells
disomic for chromosome II (Dephoure et al. 2014). We
identified 31 of these in our analysis. Eleven out of 31
(35.5%) aggregated in disome II cells with a functional pro-
teasome. In disome II rpn6-1 cells, we identified 41 of
these 67 proteins. Twenty-one (51.2%) of these were en-
riched in aggregates (Fig. 5E). We then asked whether
the 67 proteins that were typically degraded when dupli-
cated in disome II cells were enriched in aggregates
when proteasome function is compromised. In cells
with normal proteasome function, the 67 proteins had a
mean enrichment of 1.9 (log2 0.92) in disome II aggregates.
In disome II rpn6-1 cells, theirmean enrichment increased
to 4.0 (log2 2.0), indicating that many of these usually de-
graded proteins are now deposited in protein aggregates
(Fig. 5F).
We next determined the effects of protein stability on
the choice between degradation and aggregation by ana-
lyzing the origin recognition complex (ORC), in which
some subunits are degraded when in excess while others
are not (Dephoure et al. 2014). The ORC is a six-subunit
complex essential for the initiation of DNA replication
(Bell et al. 1993). All six subunits are encoded on different
chromosomes in yeast.
Orc2 levels are mostly attenuated (reduced to 1.1
[log2 0.16] relative to WT) by degradation when the
ORC2 gene is present in two copies instead of one (Fig.
5G; Dephoure et al. 2014; ). In contrast, Orc5 is not atten-
uated (present at 1.8 [log2 0.88] relative toWT) by degrada-
tion but is highly enriched in aggregates when encoded by
two gene copies (Fig. 5G,H). Tomimic stoichiometric im-
balance, we transiently overexpressed ORC2 and ORC5
individually from the galactose-inducible GAL1-10 pro-
moter. Half-life measurements showed that overproduced
Orc5 was twice as stable as overproduced Orc2 (Fig. 5I,J).
We conclude that the stability of a protein can determine
whether it aggregates or is degraded when produced in ex-
cess. Our data further indicate that surprisingly subtle
half-life differences can determine a protein’s dosage com-
pensation fate. What minimal half-life is required for a
protein to be eliminated by degradationwhen in excess re-
mains to be determined.
Dosage compensation by protein aggregation
Degradation of excess subunits of protein complexes
serves as a form of dosage compensation (Dephoure
et al. 2014). Can protein aggregation serve the same pur-
pose by sequestering excess subunits in an inaccessible ag-
gregate compartment? To address this question, we
quantified the relative abundance of proteins that re-
mained in the soluble fraction following aggregate isola-
tion in yeast strains disomic for chromosome II or XII
and compared it with their abundance in extracts prior
to aggregate removal (referred to here as total lysate) (Sup-
plemental Fig. S1A).We observed a small but nevertheless
significant difference in relative abundance of proteins en-
coded on euploid chromosomes between soluble fractions
and total lysates (Fig. 6A,B; Supplemental Data S5), which
is consistent with the observation that proteins encoded
on euploid chromosomes are also found enriched in aggre-
gates isolated from aneuploid cells (Fig. 1C). However,
depletion of proteins encoded on disomic chromosomes
from the soluble fraction was much more dramatic. Their
mean relative abundance in the soluble fraction was no-
ticeably decreased to 1.59-fold (log2 0.67) compared with
1.66-fold (log2 0.74) in total lysates for disome II and
1.69-fold (log2 0.76) compared with 1.77-fold (log2 0.82)
for disome XII (Fig. 6A,B; Supplemental Data S5).
The decrease of disome-encoded proteins in the soluble
fraction could be due tomany proteins experiencing small
amounts of aggregation or a few proteins aggregating to a
large degree. To distinguish between these possibilities,
we first calculated the change in levels for each protein
by subtracting protein levels in the soluble fraction from
those in the total lysate. We then pooled the data from
the disome II and disome XII analysis and generated two
bins: proteins that were encoded on disomic chromo-
somes and proteins encoded on euploid chromosomes.
As expected, the changes in levels of the 6495 proteins en-
coded by euploid chromosomes were evenly distributed
(Fig. 6C; gray bars); changes in levels of the 575 proteins
encoded by disomic chromosomes were not. Both the
mean and skew significantly deviated from the expected
distribution (Fig. 6C). Of the 575 disome-encoded pro-
teins, 147 (26%) were depleted by 1.15-fold (log2 0.2) in
Brennan et al.
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Figure 5. Protein half-life determines whether a protein aggregates or is degraded. (A) Proteins encoded on duplicated chromosomeswere
separated into three categories: aggregated, degraded, and neither. Aggregated proteins (red) and degraded proteins (blue) were defined as in
Figure 4A. Proteins that were identified in our analysis and that by Dephoure et al. (2014) but did not pass the threshold for aggregation or
degradation were considered neither aggregated nor degraded (gray). The heteromeric interface sizes of the proteins in each category are
plotted as box plots, with whiskers representing the 10th–90th percentile. (∗∗∗∗) P <0.0001; (∗∗) P<0.01; (n.s.) not significant, Mann-Whit-
ney test. (B) The change in levels of proteins encoded on chromosome II in disome II in total lysates of cells treated with 100 µMMG-132
(MG) and 10 mM chloroquine (CQ) relative to WT (data from Dephoure et al. 2014). Examples of aggregating proteins as determined in
Figure 1C and of degraded proteins as determined by Dephoure et al. (2014) are shown. White bars indicate relative levels immediately
before the addition ofMG-132 and chloroquine, and gray bars and black bars indicate relative levels 90 and 300 sec thereafter, respectively.
(C ) Mean levels of all aggregating proteins as measured in B at each time point. Error bars indicate SEM. (n.s.) Not significant, Wilcoxon
matched-pairs signed rank test. (D) Disome II rpn6-1 (A40196) or WT (A23504) cells were grown to exponential phase at 30°C in SC me-
diumcontaining light lysine andheavy lysine, respectively, and aggregating proteinswere identified. Lines indicatemean and SD. (∗∗∗∗) P<
0.0001, Mann-Whitney test. (E) Proteins considered degraded when duplicated by Dephoure et al. (2014) were examined in aggregates pu-
rified from disome II cells (shown in Fig. 1C) and disome II rpn6-1 cells (shown in D). A protein was considered to aggregate when it was
enriched by more than log2 1.27 in aggregates (red) and not aggregated when enriched by less than log2 1.27 (gray). “No ID” indicates pro-
teins that were not identified in aggregates (white). (∗∗) P <0.01, cumulative distribution function for a binomial distribution. (F ) Degree of
aggregation was determined for all proteins in E in disome II aggregates and disome II rpn6-1 aggregates. Bars represent SD. (∗∗) P <0.01,
Mann-Whitney test. (G,H) Relative protein levels as determined by Dephoure et al. (2014) (G) and relative aggregation as measured in
Figure 1C (H) for origin recognition complex (ORC) subunits when encoded by disomic chromosomes. (n.d.) Not detected in aggregates.
(I,J) Cells were grown to exponential phase at 30°C in YEPmedium containing 2% raffinose. Expression of HA-taggedORC2 (A40197) and
ORC5 (A40198)was inducedwith2%galactose for 20min.Next, protein synthesiswashaltedby theadditionof 2%glucoseand0.5mg/mL
cycloheximide (t =0). Protein levels were determined. Pgk1 was used as a loading control (I ). Protein levels were quantified relative to the
loading control and normalized to the 0-min time point (J). (Dis) Disome; (ln) natural logarithm.
Protein aggregation in aneuploid cells
GENES & DEVELOPMENT 1039
 Cold Spring Harbor Laboratory Press on July 24, 2020 - Published by genesdev.cshlp.orgDownloaded from 
the soluble fraction compared with total lysate (Fig. 6E),
and 12%were depleted by 1.32-fold (log2 0.4). Full attenu-
ation, defined as a 1.74-fold (log2 0.8) decrease, occurred
for 3% of proteins (Fig. 6E). This indicates that reduction
in protein levels for duplicated proteins in the soluble frac-
tion is largely due to many proteins decreasing by a small
degree. However, full attenuation by aggregation also
occurs.
How does dosage compensation by aggregation com-
pare with dosage compensation by protein degradation?
Previous studies showed that 21% of proteins decrease
by 1.52-fold (log2 0.6) due to either down-regulation of
gene expression or protein degradation (Dephoure et al.
2014). To assess what fraction of the proteome is attenuat-
ed solely by protein degradation, we subtracted protein
levels from RNA levels in the data set published by
Dephoure et al. (2014). We then pooled data for disome
II and disome XII, allowing us to examine 7328 measure-
ments for proteins encoded on euploid chromosomes
and 629 measurements for disome II- and disome XII-en-
coded proteins. As expected, the changes in levels of the
7328 proteins encoded by euploid chromosomes were
evenly distributed (Fig. 6D, gray bars). The 629 proteins
encoded by disomic chromosomes behaved differently.
Both the mean and skew were larger than observed in
the expected distribution (Fig. 6D). Of the 629 disome-en-
coded proteins, 209 (33.2%) were depleted by 1.15-fold
(log2 0.2) relative to RNA levels (Fig. 6E), and 18.4% were
depleted by 1.32-fold (log2 0.4). Full attenuation (1.74-fold
[log2 0.8]) occurred for 6.4% of proteins (Fig. 6E). We
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Figure 6. Dosage compensation by protein
aggregation. (A,B) Total lysate and soluble
fractions, obtained as described in Figure
1A, were analyzed for disome II (A) and dis-
ome XII (B). Proteins encoded by euploid
chromosomes (gray) and proteins encoded
by the duplicated chromosome (red). Data
are represented as box plots, with whiskers
extending to 10th and 90th percentiles.
Means are indicated below. The top dashed
line represents the theoretical mean for pro-
teins encoded by the duplicated chromo-
some. (∗∗∗∗) P<0.0001, Mann-Whitney test.
(C ) Changes in protein levels due to aggrega-
tion for proteins quantified in A and B were
calculated for every protein by subtracting
its log2 ratio in the soluble fraction from its
log2 ratio in the total lysate. Disome II and
disome XII data were pooled and separated
into two subsets: euploid chromosome-en-
coded proteins (gray) and disomic chromo-
some-encoded proteins (red). Frequency
distributions of each subset were then gener-
ated using a bin size of 0.1. Distributions
were fit to Gaussian curves for euploid
(dashed line) and disome (solid line). P-value
shows that mean change of disome-encoded
proteins is significantly different from the
mean change of euploid-encoded proteins
(Mann-Whitney test). (D) Changes in protein
levels due to degradation for disome II and
disome XII were calculated by subtracting
the relative protein level from the relative
mRNA level for each gene as measured by
Dephoure et al. (2014). Frequency distribu-
tions were generated, and curve fitting was performed on the pooled data as in C. P-value shows that mean change of disome-encoded
proteins is significantly different from the mean change of euploid-encoded proteins (Mann-Whitney test). (E) The percentage of proteins
encoded by the duplicated chromosome that decreased in levels by at least a log2 of 0.2, 0.4, 0.6, and 0.8 due to aggregation (red bars) was
calculated using the data described inC, and the percentage of those that decreased due to degradation (blue bars) was calculated using the
data inD. (∗∗∗∗) P< 0.0001; (∗∗) P <0.01; (∗) P <0.05, χ2 test. (F ) The correlation between protein levels in total lysate and reduction in levels
due to aggregation was determined for proteins encoded on duplicated chromosomes from the pooled data set of disome II (A) and disome
XII (B). Spearman correlation of 0.3589 (P <0.0001). Dashed lines indicate thresholds for proteins being considered dosage-compensated by
aggregation (Y-axes) or degradation (X-axes). The number of proteins that fall into each quadrant is indicated (note that 19 data points fell
outside the range of the axes but were included in the calculations). (G) Proteins encoded on duplicated chromosomes were separated into
two categories: Dosage-compensated proteins (red) were defined as their levels being reduced by at least log2 0.4 in the soluble fraction
relative to the total lysate. “Not dosage-compensated” proteins (gray) were defined as their levels being reduced by less than log2 0.4.
Mean levels in total lysates are plotted; error bars indicate 95% confidence intervals. (∗∗∗∗) P <0.0001, Mann-Whitney test. (Dis) Disome.
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conclude that small degrees of attenuation of disome-en-
coded proteins occur by both aggregation and degradation.
Reduction to levels approaching those seen in euploid
cells occurs predominantly through protein degradation.
Finally, we asked whether dosage compensation of a
particular protein was mediated by both protein degrada-
tion and aggregation or one or the other in our disome II
and XII data set. First, we determined whether a corre-
lation existed between the relative abundance of a dis-
ome-encoded protein in the total lysate and the degree
of dosage compensation by aggregation. This was the
case, indicating that proteins with higher relative expres-
sion levels are more likely to be dosage-compensated
by aggregation (Fig. 6F). To further assess whether protein
aggregation and degradation are mutually exclusive, we
analyzed the data using cutoffs defined previously
(Dephoure et al. 2014). Disome-encoded proteins present
in the total lysate at levels below 1.52 (log2 0.6; instead
of the expected 2 [log2 1]) were considered dosage-compen-
sated by degradation. Disome-encoded proteins that were
depleted in the soluble fraction by at least 1.52 (log2 0.6)
compared with the total lysate were considered dosage-
compensated by aggregation. Based on these criteria,
only nine out of 575 (1.6%) disomic proteins were dos-
age-compensated by both aggregation and degradation,
as evident by the fact that the top left quadrant in the
graph in Figure 6F is underpopulated (Fisher’s exact test,
P= 0.0011). We also asked whether disome-encoded pro-
teins that are dosage-compensated by aggregation are pre-
sent in total lysates at the twofold level expected for
disome-encoded proteins. This was the case (Fig. 6G),
demonstrating that they are not degraded. In contrast, lev-
els of proteins considered not dosage-compensated by ag-
gregation were lower in total extracts. Our data indicate
that excess proteins are dosage-compensated by aggrega-
tion or degradation but rarely by both.
Discussion
Our analysis of protein aggregation in disomic yeast
strains provided insight into why protein aggregation is
a universal feature of the aneuploid state and revealed pro-
tein aggregation as a means of dosage compensation. This
dosage compensation not only is relevant in aneuploid
cells but could very well contribute to stoichiometry con-
trol in euploid cells that encounter stoichiometric imbal-
ances due to transient imbalances caused by variability in
gene expression. Remarkably, aggregation is nearly as ef-
fective as protein degradation at lowering levels of excess
proteins. Whether protein aggregation serves a cytopro-
tective role in situations where high levels of unassem-
bled complex subunits are present in cells (i.e., in
aneuploid cells) is an important question that remains to
be answered.
Which proteins aggregate in aneuploid cells?
Our analysis of protein aggregation in a series of disomic
yeast strains provided insight into why protein aggrega-
tion is a universal feature of the aneuploid state. We iden-
tified proteins encoded on the disomic chromosomes as
well as proteins encoded on euploid chromosomes to be
enriched in aggregates.
Among the proteins found in aggregates of multiple dif-
ferent aneuploid strains, ribosomes were the most promi-
nent. Ribosomes comprise ∼75% of aggregates isolated
from both euploid cells and aneuploid cells but aggregate
more readily in aneuploid cells, as judged by the fact that
they harbor more aggregates. Why ribosomes are enriched
in aggregates of disomic yeast strains is not clear. Perhaps
a higher fraction of ribosomes is defective in disomic yeast
strains, causing them to aggregate.
Ribosomes were not the only proteins commonly found
in aggregates of aneuploid yeast strains. Interestingly, the
proteins that aggregated in multiple different aneuploid
cell lines also aggregated when protein quality control
pathways were impaired. This observation raises the
interesting possibility that proteins that are especially
dependent on protein quality control pathways to main-
tain their solubility are “canary in the coalmine” proteins
of the state of cellular protein quality control. It will
be interesting to determine which properties make the
canary proteins so sensitive to perturbations in protein
homeostasis.
We also analyzed proteins that aggregate because their
encoding genes were duplicated due to disomy. These
proteins were strongly enriched for subunits of protein
complexes, leading us to hypothesize that subunits of het-
eromeric protein complexes present at levels twice that of
their binding partners are prone to aggregation. We went
on to demonstrate that this was true in the case of the
eIF2 complex. Our analysis of human trisomic cell lines
further revealed that aggregation of proteins that are in ex-
cess is surprisingly sensitive to alterations in gene expres-
sion. Changing gene expression by as little as 50% causes
aggregation of many proteins.
Cellular response to excess subunits of protein
complexes
Our findings have important implications for euploid
cells. Although expression of subunits of the same com-
plex is tightly coordinated in eukaryotes (Li et al. 2014;
Taggart and Li 2018), it is likely that even euploid cells en-
counter transient stoichiometric imbalances. Variability
in expression of individual subunits can lead to stoichio-
metric imbalances, where individual subunits lack bind-
ing partners or where protein complexes are only partially
assembled.
Our study shows that 61.5%of proteins either aggregate
or are degraded when produced in excess. Among proteins
that function in complexes, 73% of proteins either aggre-
gate or are degraded. Interestingly, the 27% that are nei-
ther aggregated nor degraded have significantly smaller
heteromeric protein-binding interfaces than protein com-
plex subunits that aggregate or are degraded. We propose
that excess proteins that do not aggregate or get degraded
are simply less aggregation-prone and lack the signals that
target them for degradation. Whether there are features
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that distinguish proteins that are degraded from proteins
that are aggregated remains to be determined.
Our data also indicate that aggregation and degrada-
tion of proteins encoded on disomic chromosomes is
largely mutually exclusive. Intuitively, this makes sense:
If excess proteins are degraded, there is no excess protein
to aggregate. What determines whether excess proteins
are degraded or aggregate is their half-life when unbound.
This is what we observed for Orc2 and Orc5. Overex-
pressed Orc2 has a shorter overall half-life, presumably
because excess Orc2 is degraded. Orc5 has a longer over-
all half-life when overexpressed because excess Orc5 ag-
gregates. What was surprising was that a change in
protein half-life of twofold appeared to determine wheth-
er an overexpressed protein aggregates or is eliminated
by degradation. What determines the half-life of a pro-
tein and what minimal half-life is required to be elimi-
nated by degradation when in excess remains to be
determined.
Dosage compensation by protein aggregation
Our results indicate that protein aggregation is nearly as
effective as protein degradation at lowering levels of ex-
cess proteins. Using stringent cutoffs to designate a pro-
tein being dosage-compensated, we found that 12% of
disome-encoded proteins were depleted from the soluble
fraction by 1.32-fold due to aggregation; depletion by pro-
tein degradation occurred for 18.4% of proteins.
We hypothesize that protein aggregation could serve a
cytoprotective function that shields aneuploid and eu-
ploid cells from toxic activities of excess protein complex
subunits. Testing this hypothesis requires the develop-
ment of methods that prevent protein aggregation in an-
euploid cells, a task that has proven difficult. Protein
aggregation as a cytoprotective mechanism has been pro-
posed during cellular and organismal aging (David et al.
2010; Walther et al. 2015), suggesting that it could also
serve this function in aneuploid cells. However, it is
worth noting that the aggregation that occurs during ag-
ing does not function to normalize stoichiometric imbal-
ances but rather to protect cells from highly abundant
proteins that exceed their solubility during aging. Protein
aggregation has also been found to protect cells during
stress by sequestering misfolded proteins and targeting
them to specific subcellular compartments (Escusa-Toret
et al. 2013; Miller et al. 2015). Aggregation of disease-
inducing proteins such as amyloid β, which is associated
with Alzheimers disease, has also been proposed to
protect neurons from toxic oligomers (Caughey and
Lansbury 2003). Our observation that widespread aggre-
gation serves the purpose of protecting cells from gene
dosage excess raises the intriguing possibility that aggre-
gation may be one mechanism that allows cancer cells to
tolerate aneuploidy. Analysis of the degree of protein ag-
gregation in cancer cell lines that are highly aneuploid
and thus experience large-scale stoichiometric imbalanc-
es yet have high proliferative potential could shed light
on this question.
Materials and methods
Yeast strains, plasmids, and growth conditions
All yeast strains are derivatives of W303 and are described in
Supplemental Table S1. Primers are listed in Supplemental
Table S2, and plasmids are listed in Supplemental Table S3. Yeast
strains were generated and manipulated as described previously
(Guthrie and Fink 1991). Cells were grown at 30°C in YEP supple-
mented with 2% raffinose (YEP-R), 2% raffinose + 2% galactose
(YEP-RG), or 2% glucose (YEP-D) or in synthetic complete medi-
um supplemented with 2% glucose (SC-D). For SILAC experi-
ments, cells were grown overnight in SC-D medium containing
100 µg/mL heavy (13C6 15N2 [K8]; Cambridge Isotope Labs) or
light (K4) (Sigma-Aldrich) L-lysine. Cells were then diluted to
OD600 = 0.05 to 0.1 and grown to OD600 = 0.4–1.0 before harvest-
ing lysates. Strains harboring temperature-sensitive mutations
in NDC10 or RPN6 were grown overnight at room temperature
and grown to exponential phase at room temperature before shift-
ing to the semipermissive temperature of 30°C. ndc10-1 strains
were grown for 4 h and rpn6-1 strains were grown for 6 h at
30°C before harvesting for aggregate purification. For radicicol
treatments, cells harboring a deletion in the gene encoding the
drug transporter Pdr5 were grown to exponential phase in SC
medium at 30°C, and radicicol (Cayman Chemical Company)
or DMSO was added to the culture at a final concentration of
70 µM. Cells were grown in the presence of radicicol or DMSO
for 30 min at 30°C before harvesting for aggregate purification.
Disomes used in this study are derivatives of those published in
Torres et al. (2007). Gene deletions, fusion proteins, and promoter
swaps were generated using PCR-based methods (Longtine et al.
1998) in a WT W303 yeast strain. Disomes carrying gene manip-
ulations were constructed by crosses. Karyotypes of key disomic
strains were verified by whole-genome sequencing.
GCD11-HA andGCD11Δwere generated by PCR-based meth-
ods (Longtine et al. 1998). GCD11-HA with its native promoter
and terminator was cloned into p24 by Gibson cloning (Gibson
et al. 2009) and integrated at ura3 by NcoI digestion. The
pSUI2/SUI3 CEN plasmid was constructed by Gibson cloning
(Gibson et al. 2009) SUI2 and SUI3 with their native promoters
and terminators into p158.
Cell culture and SILAC labeling of RPE-1 cells
RPE-1WT (control) cells were grown in heavy (K8) SILACDMEM
(DMEMwith high glucoseminus glutamine, lysine, and arginine)
supplemented with 10% dialyzed FBS (Gibco), 50 µg/mL K8 ly-
sine (Cambridge Isotope Labs), 85 µg/mL arginine (Sigma-Al-
drich), and 2 mM glutamine/1 mM sodium pyruvate (Thermo
Fisher). RPE-1 cells trisomic for chromosome 12 or 21were grown
in light (K0) SILAC DMEM (same formulation as above, with
50 µg/mLK0 lysine; Sigma-Aldrich). Cells were cultured for eight
generations prior to testing K8 labeling efficiency byMS and then
expanded for harvest at passage 10. Prior to harvest, cells were
treated with 25 µM chloroquine for 16 h followed by addition of
1 µMMG-132 (Calbiochem) for 6 h to induce protein aggregation.
Cells were harvested by trypsinization, neutralized in SILAC
DMEM, and washed with PBS; an equal number of heavy and
light cells were mixed (WT+Ts12; WT+Ts21), treated with
sodium azide, and snap-frozen for aggregate purification.
Aggregate purification and analysis
Aggregate purification was carried out based on methods pub-
lished by Koplin et al. (2010) with some modifications to the
cell lysis procedure. Cells were grown to exponential phase in
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SC medium under the conditions indicated above. Sodium azide
was added to a final concentration of 50 mM in the cultures be-
fore pelleting cells. Ten OD600 units of cell pellets were washed
with 50 mM sodium azide and snap-frozen in liquid nitrogen.
Frozen pellets were then resuspended in 1 mL of buffer contain-
ing 1 M sorbitol, 100 mM sodium citrate, 60 mM EDTA, 10 mM
DTT (pH 7.0; SCED), 1 mM PMSF, and 2× protease inhibitor
tablets (Roche). Cells were pelleted, resuspended in 1 mL of
SCED buffer containing 1 mg/mL 20T zymolyase (MP Biomed-
icals), and rotated gently for 8 min at room temperature. Digest-
ed cells were pelleted by spinning at 250g for 5 min at 4°C.
Pellets were washed gently in ice-cold SCED buffer containing
1 mM PMSF and 2× protease inhibitors. Cells were lysed by re-
suspending in 1.5 mL of ice-cold lysis buffer containing 20 mM
NaPi (pH 6.8), 10 mM DTT, 1 mM EDTA, 0.1% Tween 20
(Sigma-Aldrich), 1 mM PMSF, and 5× protease inhibitors and
then sonicated for eight pulses at output level 4 and 50% duty
cycle. Lysates were cleared by spinning at 850g for 2 min at 4°
C, yielding the total lysate fraction. Protein concentrations of
the cleared lysate were determined by Bradford (Bio-Rad). For
quantitative Western blotting and Coomassie staining, samples
were diluted to the same protein concentration. A small aliquot
of the total lysate fraction was taken for analysis, and aggregates
were pelleted from the remainder of the total lysate by spinning
the extract at 16,000g for 20 min at 4°C. The supernatant was
removed and reserved as the soluble fraction. Pellets were then
washed twice by resuspending in buffer containing 20 mM
NaPi (pH 6.8), 2% NP40, 1 mM PMSF, and 2× protease inhibi-
tors and then sonicated for six pulses at output level 4 and
50% duty cycle. A final wash was carried out in buffer contain-
ing 20 mM NaPi (pH 6.8), 1 mM PMSF, and 2× protease inhibi-
tors, and then pellets were sonicated for four pulses at output
level 2 and 60% duty cycle, yielding the aggregate fraction.
All centrifugations during the wash steps were at 16,000g for
20 min at 4°C.
For Western blot analysis and Coomassie staining analysis, to-
tal lysate fractions were boiled in SDS loading buffer. Aggregate
fractions were resuspended in buffer containing 200 mM NaPi
(pH 6.8), 5% SDS, 8 MUrea, 10 mMDTT, and 0.01% bromophe-
nol blue (HU buffer) and then vortexed at 1500 rpm for 5 min at
60°C. For Coomassie staining, SDS-PAGE gels were stained
with Imperial protein stain (Thermo Scientific) per the manufac-
turer’s instructions. For Western blotting, proteins were separat-
ed by SDS-PAGE, transferred to nitrocellulose membranes, and
detected by the following antibodies: Hsp104-eGFP was detected
using a mouse anti-GFP antibody (JL-8 epitope; Clontech) at a
dilution of 1:1000. Pgk1 was detected using a mouse anti-Pgk1
antibody (Invitrogen) at a 1:10,000 dilution. Gcd11-HA was de-
tected using a mouse anti-HA antibody (HA.11 epitope; BioLe-
gend). Quantification was performed using Fiji software
(Schindelin et al. 2012).
Ribosome purification
Cells were grown to exponential phase, pelleted by centrifuga-
tion, washed with water, and then snap-frozen in liquid nitro-
gen. Cells were incubated in lysis buffer (20 mM HEPES at
pH 7.4, 100 mM potassium acetate, 2 mM magnesium acetate,
3 mM DTT, protease inhibitor tablets, 1 mg/mL zymolyase)
for 5 min at 4°C and then lysed by French press (Sim-Aminco).
The lysate was cleared by centrifuging at 19,000 rpm (Beckman
Coulter, JA25.50 rotor) for 20 min at 4°C. The cleared lysates
were applied to a 30% sucrose gradient containing 20 mM
HEPES (pH 7.4), 500 mM potassium acetate, 2 mM magnesium
acetate, and 3 mMDTT. Ribosomes were pelleted by centrifuga-
tion at 50,000 rpm (Beckman Coulter, type 70 Ti rotor) for 4 h at
4°C. The pellet was dissolved in lysis buffer and analyzed by
SDS-PAGE.
Quantitative proteomics of yeast aggregates
Five OD600 units of heavy-labeled cells were mixed with five
OD600 units of light-labeled cells, and aggregates were harvested
as described above. Purified SILAC-labeled aggregateswere boiled
in SDS lysis buffer (50 mMTris at pH 7.5, 2 mM EDTA, 2% SDS)
and separated on 4%–12% Tris-glycine by SDS-PAGE gels (Invi-
trogen). Proteins were visualized by Coomassie staining (45%
methanol, 5% glacial acetic acid, 3 g/L Coomassie brilliant blue
G-250) and subjected to gel band cutting (Shevchenko et al.
2006), destaining, and in-gel Lys-C (Wako Chemicals) digest at a
50:1 protein to protease ratio to liberate peptides. Following
digest, the buffer-containing peptides and gel slices were acidified
using 50% acetonitrile/5% formic acid, and recovered peptides
were vacuum-centrifuged to near dryness. Each gel fraction was
desalted via StageTip, dried via vacuum centrifugation, and re-
constituted in 5% acetonitrile and 5% formic acid for liquid chro-
matography-tandem MS (LC-MS/MS) processing.
Quantitative proteomics of RPE-1 cell aggregates
RPE-1 cells were cultured and treated as described above. Aggre-
gate purification was carried out as described for yeast cells with
the following modifications. Cells were collected, treated with
sodium azide, and snap-frozen. Frozen cell pellets were resus-
pended in cold lysis buffer (described above) and sonicated. Sam-
ples were analyzed using the same mass spectrometric method
and data processing workflow as yeast aggregates (see below).
LC-MS
MS data were collected using a Q Exactive mass spectrometer
(Thermo Fisher) coupledwith a Famos autosampler (LCPackings)
and an Accela600 LC pump (Thermo Fisher). Peptides were sepa-
rated on an ∼18-cm column with 100 µm inner diameter packed
with Accucore150 resin (2.6 μm, 150 Å; Thermo Fisher Scien-
tific);∼1 µg of peptides was loaded onto the column for each anal-
ysis. Peptides were separated with a 2-h gradient of 5%–26%
acetonitrile in 0.125% formic acid with a flow rate of ∼300 nL/
min. For the MS1 scan, resolution was set to 70,000 with an au-
tomatic gain control (AGC) target of 1 × 106 and a maximum in-
jection time of 250 msec. We selected the top 20 precursors for
HCD MS2 analysis with the following parameters: resolution,
17,500; AGC, 1 × 105; maximum injection time, 90 msec; isola-
tion window, 2 Th; normalized collision energy (NCE), 25; and
centroid spectrum data type. In addition, unassigned and singly
charged species were excluded from MS2 analysis, and dynamic
exclusion was set to automatic.
For data analysis, mass spectra were processed using a Sequest-
based in-house software pipeline. MS spectra were converted to
mzXML using a modified version of ReAdW.exe. MS2 spectra
were searched with a database, including all predictive ORFs for
entries from the yeast SGD (http://www.yeastgenome.org/
download-data; downloaded March 12, 2014). For human aggre-
gate samples, database searching included all entries from the hu-
man UniProt database (August 10, 2011). Both yeast and human
databases were concatenated with a reverse database composed
of all protein sequences in reverse order. Searcheswere performed
using a 50-ppm precursor ion tolerance. Product ion tolerance
was set to 0.03 Th. Oxidation of methionine residues (+15.995
Da) and heavy lysine (K8) incorporation (+8.0142) were set as a
variable modification. Peptide spectral matches (PSMs) were
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altered to a 1% FDR (Elias and Gygi 2007, 2010). PSM filtering
was performed using a linear discriminant analysis, as described
previously (Huttlin et al. 2010), while considering the following
parameters: XCorr,ΔCn,missed cleavages, peptide length, charge
state, and precursormass accuracy. PSMswere identified, quanti-
fied, collapsed to a 1% FDR, and then further collapsed to a final
protein-level FDR of 1%. Furthermore, protein assembly was
guided by principles of parsimony to produce the smallest set of
proteins necessary to account for all observed peptides. Four gel
band regions were cut per sample (individual lanes) of the SDS-
PAGE gel; these four regions were processed separately, and
each is an independent MS sample (to decrease the complexity
of peptides in each run). Protein assembly was used to group
the four runs of a given sample together for batched analysis
and calculation of log2(heavy/light) ratios. The resulting data
were filtered for SILAC-quantified proteins based on the summed
signal to noise for heavy and light peptides; contaminant peptides
identified in the search were removed at this step. An intensity
cutoff of 10 was applied for summed heavy plus light channels,
and each individual channel had an intensity cutoff of 5 (to avoid
identifying proteins with an intensity of 0 in either the light or
heavy channel; i.e., proteins found in only one condition or the
other). A SILAC-labeled total lysate reference sample (to allow
for normalization of SILAC mixing) was obtained as described
above. Proteins were pelleted by trichloroacetic acid (TCA) pre-
cipitation, dried via vacuum centrifugation, and digested with
Lys-C. Resulting peptides were desalted using StageTips, and
MS data collection and analysis were performed as described
above for aggregate samples.
SILAC MS of total lysate and soluble fractions
Total lysate samples were prepared, and soluble fractions (super-
natant after aggregate isolation) were collected as described
above. Approximately 800 µg of protein per sample was pelleted
via TCA precipitation and dried via vacuum centrifugation. Sam-
ples were reduced and alkylated followed by digestion with Lys-
C. Resulting peptides were desalted using StageTips, and samples
were dried via vacuum centrifugation.
Each sample was fractionated using offline basic pH reversed-
phase chromatography (BPRP HPLC) (Wang et al. 2011). We
used an Agilent 1200 pump equipped with a degasser and a pho-
todiode array (PDA) detector (set at 220- and 280-nmwavelength)
from Thermo Fisher Scientific. Peptides were subjected to a 50-
min linear gradient from 5% to 35% acetonitrile in 10 mM am-
monium bicarbonate (pH 8) at a flow rate of 0.6 mL/min over
an Agilent 300Extend C18 column (3.5-μm particles, 4.6 mm
ID, and 220mm in length). The peptide mixture was fractionated
into a total of 96 fractions, which were consolidated into 24, from
which 12 nonadjacent samples were analyzed (Paulo et al. 2016).
Samples were subsequently acidified with 1% formic acid and
vacuum-centrifuged to near dryness. Each consolidated fraction
was desalted via StageTip, dried again via vacuum centrifugation,
and reconstituted in 5% acetonitrile and 5% formic acid for LC-
MS/MS processing. Samples were analyzed using a Q Exactive
mass spectrometer using the same instrument method and data
processing as described above for yeast aggregate samples.
Real-time RT-qPCR
Cells were grown to exponential phase in SCmedium containing
2% glucose, as for aggregate purification. Five OD600 units of cul-
ture were pelleted by centrifugation at 3000 rpm for 2min at 4°C.
The pellet was resuspended in 1 mL of cold SC medium, trans-
ferred to a 2-mL microfuge tube, and pelleted by centrifugation
at 3000 rpm for 2min at 4°C. The pellet was flash-frozen in liquid
nitrogen and stored at −80°C. To extract total RNA, ∼200 μL of
glass beads, 400 μL of TES buffer (10 mM Tris at pH 7.5, 10 mM
EDTA, 0.5% SDS), and 400 µL of acid phenol:chloroform (pH
4.5) were added to the cell pellet, and the tubes were vortexed
for 30 min at 65°C. The phases were separated by centrifugation,
and the top phase was transferred to a new tube containing 1 mL
of 120 mM sodium acetate in ethanol to precipitate RNA at 4°C.
Precipitates were collected by centrifugation and resuspended in
100 μL of DEPC-treated water. Total RNA was further purified
using the RNeasy minikit (Qiagen), including DNase treatment,
according to the manufacturer’s instructions. cDNAwas synthe-
sized from 750 ng of total RNA using the SuperScript III first
strand synthesis supermix kit (Invitrogen) with random hexamer
primers according to the manufacturer’s instructions. Real-time
qPCR reactions were run using the SYBR Premix Ex Taq Perfect
real-time kit (TaKaRa Bio) and a Roche LightCycler 480 (Roche)
according to the manufacturer’s instructions. qPCR primers are
listed in Supplemental Table S2.
Turnover measurements for aggregated proteins
Protein turnover for aggregated proteins in disome II cells was de-
termined by examining protein levels relative toWT before treat-
ment with MG-132 and choloroquine and 90 and 300 sec
thereafter. Data were generated by Dephoure et al. (2014).
Orc protein half-life measurements
Cells were grown to exponential phase at 30°C in YEP medium
containing 2% raffinose. Expression of HA-tagged ORC2 and
ORC5 was induced by diluting cultures into YEP medium con-
taining 2% raffinose and 2% galactose for 20 min. The 0-min
time point was taken, and protein synthesis was halted by the ad-
dition of 2% glucose and 0.5 mg/mL cycloheximide (Sigma-Al-
drich). Time points were taken at the indicated times after the
addition of glucose and cycloheximide. For each time point,
∼0.5 OD600 units of culture were pelleted by centrifugation at
3000 rpm for 2 min at 4°C. Cells were incubated at 4°C in 5%
TCA for at least 10 min. Cell pellets were washed once with ace-
tone and dried. Cells were lysed with glass beads in 100 μL of lysis
buffer (50 mM Tris-Cl at pH 7.5, 1 mM EDTA, 2.75 mM dithio-
threitol [DTT], complete protease inhibitor cocktail [Roche])
with a bead beater. Samples were boiled in 1× SDS loading buffer.
Following SDS-PAGE and transfer of proteins to a nitrocellulose
membrane, proteins were detectedwith the following antibodies.
Pgk1 was detected using a mouse anti-Pgk1 antibody (Invitrogen)
at a 1:10,000 dilution.Orc2-HAandOrc5-HAwere detected using
a mouse anti-HA antibody (HA.11 epitope; BioLegend). Quantifi-
cation was performed using Fiji software (Schindelin et al. 2012).
Protein levels were calculated by subtracting a background mea-
surement for each band, dividing the intensity of the Orc band by
the intensity of the Pgk1 band, and normalizing all time points to
the 0-min time point. Half-life calculations were made by fitting
curves to an exponential decay function in Prism (Graphpad).
SILAC MS data normalization
To account for imperfectmixing of heavy- and light-labeled cells,
log2 ratios of proteins identified in aggregates were normalized by
subtracting the average log2 ratio of all euploid-encoded proteins
in the total lysate obtained before pelleting aggregates for each
experiment.
To control for nonbiological batch effects between disomic cell
lines, each experimentwasmean-centered to 0 by subtracting the
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mean of all SILAC ratios in that experiment from all data
points. To return the normalized values to a baseline that more
closely resembles the increase in protein aggregation in disomic
strains observed in the raw data, a constant (log2 0.27) was added
to all normalized data points. This constant is the mean log2
ratio of all euploid-encoded proteins in the data set prior to
normalization.
Cutoff determination for aggregation
To decide what level of enrichment in disome aggregates consti-
tuted calling a protein aggregated, we used a 5% FDR obtained
from the analysis of aggregates obtained from a WT(heavy)–WT
(light) SILAC MS analysis. In this analysis, only 5% of identified
proteins were enriched by greater than log2 1.27 in WT(heavy)
aggregates.
Signal to noise quantification of relative aggregate burden
To account for the fact that some proteins are more abundant in
aggregates than others, aggregate burden for each disome relative
toWTwas calculated by comparing the signal to noise ratio of all
heavy-labeled proteinswith the signal to noise ratio of all light-la-
beled proteins in protein aggregates. The sum of all light-labeled
signal to noise ratio was divided by the sum of all heavy-labeled
signal to noise ratio. This ratio was then normalized by dividing
the ratio of light signal to noise ratio to the heavy signal to noise
ratio for the total lysate.
GO analysis
GOcomponent analysis was performed using the Saccharomyces
Genome Database (SGD) GO term finder (accessed October 12,
2018).
Aggregate property calculations
Disorder predictions for protein sequences were calculated using
IUPred on the “long” setting. For each sequence, per-residue dis-
order scores were averaged across the full length of the protein.
Grand average hydropathy (GRAVY) scores, isoelectric points, al-
iphatic indices, and aromaticity scores were calculated using the
YeastMine tool on SGD (accessed October 31, 2018).
Proteins not quantified due to low signal in the WT channel
In our MS analysis pipeline, peptides for which either individual
analysis channel had an intensity of <5 were discarded to avoid
identifying proteins with an intensity of 0 in either the light or
heavy channel; i.e., proteins found in only one condition or the
other because a SILAC ratio could not be calculated. We exam-
ined proteins that failed to pass the signal to noise threshold in
one channel but had a signal to noise ratio of at least twice the
threshold in the other channel. Using this method, we found
320 proteins that were quantified only in the disome channel
compared with 72 quantified in only the WT channel (Supple-
mental Data S1). Importantly, 92 of the proteins quantified
only in the disome channel were encoded by the duplicated chro-
mosome as opposed to just two duplicated gene-encoded pro-
teins quantified in only the WT channel. It is possible that
proteins that are identified exclusively in the disome channel
never aggregate in WT cells. It is also possible that with in-
creased coverage, these proteins would pass the signal threshold
in both channels. To distinguish between these possibilities, we
took advantage of a difference in coverage between two of our
replicate experiments for disome II. In the low-coverage experi-
ment (366 proteins quantified), nine proteins were not quantified
due to low signal in the WT channel. In the high-coverage exper-
iment (847 proteins quantified), we identified six of these pro-
teins, and all six passed the detection threshold in both
channels, allowing us to calculate a SILAC ratio. Four of these
six proteins were considered aggregating using 2.4-fold (log2 of
1.27) as a cutoff. We conclude that proteins that cannot be quan-
tified by SILAC MS due to low signal in WT cells are also likely
enriched in aneuploid aggregates.
Heteromeric interface size determination
We searched for subunits of heteromeric protein complexes in the
Protein Data Bank (on February 2, 2017) with >90% sequence
identity to Saccharomyces cerevisiae genes. We selected a single
heteromeric structure for each gene. For genes with multiple
structures available, we selected the structure with the greatest
number of unique subunits in the complex followed by the great-
est number of atoms present in the polypeptide chain for ties. The
total amount of heteromeric interface formed by each subunit
was calculated using AREAIMOL (Winn et al. 2011).
Statistical analysis
The statistical tests used are indicated in the figure legends, Ma-
terials andMethods, and/or Results. Values of n, the definition of
center, error bars (e.g., standard deviation and confidence inter-
vals), and significance levels are reported in the figures and/or fig-
ure legends. All box plots represent median and interquartile
range, with whiskers indicating the 10th–90th percentile. All of
the indicated statistical tests were performed using Matlab or
Prism.
Data availability
The MS proteomics data have been deposited to the ProteomeX-
change Consortium via the PRIDE (Vizcaíno et al. 2016) part-
ner repository in seven parts with the following data set
identifiers: PXD011874, PXD011875, PXD011876, PXD011877,
PXD011878, PXD011915, and PXD011916.
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